MENU
+Compare
KANT
Stock ticker: OTC
AS OF
Jun 27 closing price
Price
$0.34
Change
+$0.05 (+17.24%)
Capitalization
4.55M

KANT Kineta Inc. Forecast, Technical & Fundamental Analysis

Kineta Inc is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives... Show more

KANT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for KANT with price predictions
Jul 03, 2025

KANT's Stochastic Oscillator sits in overbought zone for 9 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

KANT broke above its upper Bollinger Band on June 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 27, 2025. You may want to consider a long position or call options on KANT as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for KANT just turned positive on June 10, 2025. Looking at past instances where KANT's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

KANT moved above its 50-day moving average on June 24, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for KANT crossed bullishly above the 50-day moving average on June 24, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 95 cases where KANT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (16.666). P/E Ratio (0.000) is within average values for comparable stocks, (58.763). KANT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.315). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (269.614).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KANT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KANT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
KANT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FGEN5.610.36
+6.86%
FibroGen Inc
MAIN61.130.97
+1.61%
Main Street Capital Corp
OCFC18.780.20
+1.08%
OceanFirst Financial Corp
TRP48.150.17
+0.35%
TC Energy Corp
EGAN6.76-0.03
-0.44%
eGain Corp

KANT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KANT has been loosely correlated with MDGL. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if KANT jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KANT
1D Price
Change %
KANT100%
N/A
MDGL - KANT
62%
Loosely correlated
-0.43%
SLNO - KANT
45%
Loosely correlated
+0.51%
VKTX - KANT
35%
Loosely correlated
+5.70%
CELC - KANT
34%
Loosely correlated
+5.75%
MDWD - KANT
29%
Poorly correlated
+1.15%
More